Page last updated: 2024-08-24

3-iodobenzylguanidine and Asymmetric Septal Hypertrophy, Familial

3-iodobenzylguanidine has been researched along with Asymmetric Septal Hypertrophy, Familial in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aronen, HJ; Jääskeläinen, P; Kuikka, JT; Kuusisto, J; Laakso, M; Lauerma, K; Peuhkurinen, K; Simula, S; Sipola, P; Vanninen, E	1

Trials

1 trial(s) available for 3-iodobenzylguanidine and Asymmetric Septal Hypertrophy, Familial

Article	Year
Cardiac adrenergic activity is associated with left ventricular hypertrophy in genetically homogeneous subjects with hypertrophic cardiomyopathy. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2003, Volume: 44, Issue:4 Topics: 3-Iodobenzylguanidine; Adult; Cardiomyopathy, Hypertrophic, Familial; Coronary Angiography; Echocardiography; Electrocardiography; Female; Humans; Hypertrophy, Left Ventricular; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Norepinephrine; Phylogeny; Radionuclide Imaging; Radiopharmaceuticals; Statistics as Topic	2003

Article

Year

Cardiac adrenergic activity is associated with left ventricular hypertrophy in genetically homogeneous subjects with hypertrophic cardiomyopathy.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2003, Volume: 44, Issue:4

Topics: 3-Iodobenzylguanidine; Adult; Cardiomyopathy, Hypertrophic, Familial; Coronary Angiography; Echocardiography; Electrocardiography; Female; Humans; Hypertrophy, Left Ventricular; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Norepinephrine; Phylogeny; Radionuclide Imaging; Radiopharmaceuticals; Statistics as Topic

2003